Patents/Assignees

Numab Therapeutics AG

6 patents in portfolio

US12503505utility2025
Multispecific Antibodies Having Specificity for Tnfα and IL-17A, Antibodies Targeting IL-17A, and Methods of Use Thereof
0 cites
US12209133utility2025
Antibodies Targeting CD137 and Methods of Use Thereof
0 cites
US12202911utility2025
Multispecific Antibody Comprising CD137 Binding Domain and PDL1 Binding Domain
0 cites
US12098203utility2024
Hetero-dimeric Multi-specific Antibody Format Targeting at Least CD3 and HSA
0 cites
US12077588utility2024
Antibodies Targeting PDL1 and Methods of Use Thereof
0 cites
US11879005utility2024
Hetero-dimeric Multi-specific Antibody Format
0 cites